3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Gastrointestinal
1
Conditions
Neoplasms
14
Lung Neoplasms
10
Colonic Neoplasms
10
Breast Neoplasms
9
Brain Neoplasms
6
Prostatic Neoplasms
4
Emergence Delirium
4
Urinary Bladder Neoplasms
3
Stomach Neoplasms
3
Respiratory Aspiration
3
Rectal Neoplasms
3
Pituitary Neoplasms
3
Neoplastic Cells, Circulating
3
Hypoxia
3
Carcinoma, Non-Small-Cell Lung
3
Carcinoma, Hepatocellular
3
Agnosia
3
Supratentorial Neoplasms
2
Postoperative Complications
2
Patient Satisfaction
2
Pain, Postoperative
2
Pain
2
Ovarian Neoplasms
2
Melanoma
2
Liver Neoplasms
2
Leukemia
2
Delirium
2
Colorectal Neoplasms
2
Uterine Neoplasms
1
Tuberculosis, Pulmonary
1
Interventions
Exercise
24
Metformin
23
Resistance Training
8
Nutrition Assessment
8
Methods
8
Tirzepatide
7
Diet Therapy
7
Diet
7
Counseling
7
Early Intervention, Educational
6
Caloric Restriction
6
Exenatide
5
semaglutide
4
Liraglutide
4
Educational Status
4
Docosahexaenoic Acids
4
Diet, Mediterranean
4
Vitamin D
3
Therapeutics
3
Surveys and Questionnaires
3
Sugars
3
Standard of Care
3
Dexamethasone
3
Yoga
2
Tablets
2
Specimen Handling
2
Progestins
2
Ovidrel
2
Nutritional Status
2
Naltrexone
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Obesity
×
Propofol
×
Clear all
NCT05518929
2024-06-07
SpO2
RenJi Hospital
Phase 4
Completed
1,090 enrolled